| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | iron ion binding | 1.40e-06 | 166 | 24 | 5 | GO:0005506 | |
| GeneOntologyMolecularFunction | aromatase activity | 9.74e-06 | 35 | 24 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.01e-05 | 115 | 24 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 1.38e-05 | 5 | 24 | 2 | GO:0052871 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 2.71e-05 | 49 | 24 | 3 | GO:0016712 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 2.90e-05 | 7 | 24 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 2.90e-05 | 7 | 24 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | heme binding | 3.21e-05 | 154 | 24 | 4 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 4.10e-05 | 164 | 24 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | integrin binding | 5.28e-05 | 175 | 24 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 6.19e-05 | 10 | 24 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 6.19e-05 | 10 | 24 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 6.19e-05 | 10 | 24 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 7.88e-05 | 194 | 24 | 4 | GO:0016705 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.07e-04 | 13 | 24 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate binding | 1.44e-04 | 15 | 24 | 2 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 1.64e-04 | 16 | 24 | 2 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 1.64e-04 | 16 | 24 | 2 | GO:0050543 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 3.76e-04 | 24 | 24 | 2 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 4.77e-04 | 27 | 24 | 2 | GO:0008391 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 5.13e-04 | 28 | 24 | 2 | GO:0036041 | |
| GeneOntologyMolecularFunction | fibronectin binding | 9.48e-04 | 38 | 24 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.05e-03 | 40 | 24 | 2 | GO:0016709 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.70e-03 | 51 | 24 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 2.34e-03 | 1189 | 24 | 6 | GO:0046914 | |
| GeneOntologyMolecularFunction | fatty acid binding | 3.09e-03 | 69 | 24 | 2 | GO:0005504 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.45e-03 | 73 | 24 | 2 | GO:0050840 | |
| GeneOntologyMolecularFunction | collagen binding | 4.23e-03 | 81 | 24 | 2 | GO:0005518 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.28e-03 | 599 | 24 | 4 | GO:0050839 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 7.27e-03 | 107 | 24 | 2 | GO:0033293 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 1.24e-02 | 766 | 24 | 4 | GO:0016491 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 1.94e-05 | 6 | 24 | 2 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 2.72e-05 | 7 | 24 | 2 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 3.62e-05 | 8 | 24 | 2 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 7.09e-05 | 11 | 24 | 2 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 8.50e-05 | 12 | 24 | 2 | GO:0042758 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 1.15e-04 | 82 | 24 | 3 | GO:1901568 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 1.17e-04 | 14 | 24 | 2 | GO:0097267 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | 1.63e-04 | 461 | 24 | 5 | GO:0006631 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 2.96e-04 | 22 | 24 | 2 | GO:1901569 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 5.82e-04 | 142 | 24 | 3 | GO:0006690 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 6.93e-07 | 59 | 25 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | tenascin complex | 8.23e-06 | 4 | 25 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.85e-04 | 17 | 25 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | integrin complex | 6.66e-04 | 32 | 25 | 2 | GO:0008305 | |
| Domain | Cyt_P450_E_grp-I | 3.58e-07 | 45 | 25 | 4 | IPR002401 | |
| Domain | Cyt_P450_CS | 6.99e-07 | 53 | 25 | 4 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 9.40e-07 | 57 | 25 | 4 | PS00086 | |
| Domain | - | 1.01e-06 | 58 | 25 | 4 | 1.10.630.10 | |
| Domain | p450 | 1.01e-06 | 58 | 25 | 4 | PF00067 | |
| Domain | Cyt_P450 | 1.16e-06 | 60 | 25 | 4 | IPR001128 | |
| Domain | Integrin_alpha_C_CS | 2.04e-04 | 16 | 25 | 2 | IPR018184 | |
| Domain | Integrin_alpha-2 | 2.60e-04 | 18 | 25 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 2.60e-04 | 18 | 25 | 2 | PF08441 | |
| Domain | Integrin_alpha | 2.60e-04 | 18 | 25 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 2.60e-04 | 18 | 25 | 2 | PS00242 | |
| Domain | Int_alpha_beta-p | 2.90e-04 | 19 | 25 | 2 | IPR013519 | |
| Domain | Int_alpha | 2.90e-04 | 19 | 25 | 2 | SM00191 | |
| Domain | FG_GAP | 3.91e-04 | 22 | 25 | 2 | PS51470 | |
| Domain | FG-GAP | 4.66e-04 | 24 | 25 | 2 | PF01839 | |
| Domain | FG-GAP | 4.66e-04 | 24 | 25 | 2 | IPR013517 | |
| Domain | - | 4.66e-04 | 24 | 25 | 2 | 4.10.530.10 | |
| Domain | Fibrinogen_a/b/g_C_2 | 4.66e-04 | 24 | 25 | 2 | IPR014715 | |
| Domain | Integrin_dom | 5.06e-04 | 25 | 25 | 2 | IPR032695 | |
| Domain | Fibrinogen_C | 5.92e-04 | 27 | 25 | 2 | PF00147 | |
| Domain | EGF | 6.19e-04 | 126 | 25 | 3 | PF00008 | |
| Domain | FBG | 6.83e-04 | 29 | 25 | 2 | SM00186 | |
| Domain | - | 7.31e-04 | 30 | 25 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 7.31e-04 | 30 | 25 | 2 | IPR014716 | |
| Domain | Fibrinogen_a/b/g_C_dom | 8.32e-04 | 32 | 25 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 8.32e-04 | 32 | 25 | 2 | PS51406 | |
| Domain | FIBRINOGEN_C_1 | 8.32e-04 | 32 | 25 | 2 | PS00514 | |
| Domain | EGF_extracell | 2.90e-03 | 60 | 25 | 2 | IPR013111 | |
| Domain | EGF_2 | 2.90e-03 | 60 | 25 | 2 | PF07974 | |
| Domain | EGF_3 | 3.69e-03 | 235 | 25 | 3 | PS50026 | |
| Domain | EGF | 3.69e-03 | 235 | 25 | 3 | SM00181 | |
| Domain | EGF-like_dom | 4.34e-03 | 249 | 25 | 3 | IPR000742 | |
| Domain | EGF_1 | 4.63e-03 | 255 | 25 | 3 | PS00022 | |
| Domain | EGF-like_CS | 4.94e-03 | 261 | 25 | 3 | IPR013032 | |
| Domain | EGF_2 | 5.16e-03 | 265 | 25 | 3 | PS01186 | |
| Domain | Growth_fac_rcpt_ | 1.83e-02 | 156 | 25 | 2 | IPR009030 | |
| Domain | fn3 | 1.97e-02 | 162 | 25 | 2 | PF00041 | |
| Domain | FN3 | 2.52e-02 | 185 | 25 | 2 | SM00060 | |
| Pathway | REACTOME_EICOSANOIDS | 9.15e-10 | 12 | 18 | 4 | MM14845 | |
| Pathway | REACTOME_EICOSANOIDS | 9.15e-10 | 12 | 18 | 4 | M27129 | |
| Pathway | REACTOME_FATTY_ACIDS | 2.52e-09 | 15 | 18 | 4 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 5.63e-09 | 18 | 18 | 4 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 5.63e-09 | 18 | 18 | 4 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.31e-08 | 25 | 18 | 4 | MM14858 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 9.28e-07 | 61 | 18 | 4 | MM14861 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 9.91e-07 | 62 | 18 | 4 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.13e-06 | 64 | 18 | 4 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.28e-06 | 66 | 18 | 4 | MM14839 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 1.81e-06 | 170 | 18 | 5 | MM15573 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.29e-06 | 21 | 18 | 3 | M27137 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 7.90e-06 | 104 | 18 | 4 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 8.21e-06 | 105 | 18 | 4 | MM14842 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 5.43e-05 | 59 | 18 | 3 | M27140 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 6.27e-05 | 176 | 18 | 4 | M27854 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 7.29e-05 | 183 | 18 | 4 | M39588 | |
| Pathway | WP_FOCAL_ADHESION | 7.93e-05 | 187 | 18 | 4 | MM15913 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.01e-04 | 12 | 18 | 2 | M27128 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.16e-04 | 76 | 18 | 3 | MM14867 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 1.39e-04 | 14 | 18 | 2 | MM15842 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.46e-04 | 219 | 18 | 4 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.49e-04 | 220 | 18 | 4 | M10320 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.56e-04 | 84 | 18 | 3 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.62e-04 | 85 | 18 | 3 | M16441 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.74e-04 | 258 | 18 | 4 | MM14572 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.86e-04 | 300 | 18 | 4 | M610 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 4.91e-04 | 26 | 18 | 2 | M47 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 6.65e-04 | 326 | 18 | 4 | MM15917 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 7.94e-04 | 33 | 18 | 2 | MM15963 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 7.94e-04 | 33 | 18 | 2 | MM15918 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 8.60e-04 | 620 | 18 | 5 | MM15193 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 1.29e-03 | 42 | 18 | 2 | M174 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.35e-03 | 43 | 18 | 2 | MM15873 | |
| Pathway | WP_VITAMIN_D_RECEPTOR_PATHWAY | 1.57e-03 | 185 | 18 | 3 | M39718 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.61e-03 | 47 | 18 | 2 | MM14925 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 1.68e-03 | 48 | 18 | 2 | MM15902 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.93e-03 | 199 | 18 | 3 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 1.93e-03 | 199 | 18 | 3 | M39402 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 3.15e-03 | 66 | 18 | 2 | M18 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.15e-03 | 76 | 18 | 2 | M27219 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 5.40e-03 | 87 | 18 | 2 | M6856 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 6.26e-03 | 302 | 18 | 3 | M39719 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 7.35e-03 | 102 | 18 | 2 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 7.35e-03 | 102 | 18 | 2 | MM15830 | |
| Pathway | WP_PI3KAKT_SIGNALING | 8.60e-03 | 339 | 18 | 3 | M39736 | |
| Pubmed | 1.84e-07 | 70 | 25 | 4 | 15128046 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 9321695 | ||
| Pubmed | Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. | 4.96e-07 | 2 | 25 | 2 | 12359049 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 17202312 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 8856503 | ||
| Pubmed | The change in tenascin expression in mouse uterus during early pregnancy. | 4.96e-07 | 2 | 25 | 2 | 9013311 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 16112640 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 15455729 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 7509489 | ||
| Pubmed | The effects of tenascin C knockdown on trabecular meshwork outflow resistance. | 4.96e-07 | 2 | 25 | 2 | 23882691 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 19748582 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 37209968 | ||
| Pubmed | Expression of tenascin in developing and adult mouse lymphoid organs. | 1.49e-06 | 3 | 25 | 2 | 7687262 | |
| Pubmed | The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. | 1.49e-06 | 3 | 25 | 2 | 12823230 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 7530141 | ||
| Pubmed | Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. | 1.49e-06 | 3 | 25 | 2 | 7694605 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 22665481 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 2.97e-06 | 4 | 25 | 2 | 11185557 | |
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 4.26e-06 | 44 | 25 | 3 | 12745259 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 22969154 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 4.95e-06 | 5 | 25 | 2 | 21466787 | |
| Pubmed | The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. | 4.95e-06 | 5 | 25 | 2 | 7512972 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 9068972 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 7512897 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 23595732 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 32581832 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 22160543 | ||
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 1383086 | ||
| Pubmed | Alpha9 and beta8 integrin expression correlates with the merger of the developing mouse eyelids. | 3.26e-05 | 12 | 25 | 2 | 10090148 | |
| Pubmed | 3.26e-05 | 12 | 25 | 2 | 10101119 | ||
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 22115758 | ||
| Pubmed | 1.03e-04 | 21 | 25 | 2 | 21408207 | ||
| Pubmed | 1.14e-04 | 22 | 25 | 2 | 27527664 | ||
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 1.47e-04 | 25 | 25 | 2 | 17170699 | |
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 1.47e-04 | 25 | 25 | 2 | 19373938 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.72e-04 | 27 | 25 | 2 | 31541017 | |
| Pubmed | 2.43e-04 | 32 | 25 | 2 | 23154389 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 3.25e-04 | 37 | 25 | 2 | 34323105 | |
| Pubmed | Sterile Inflammation Enhances ECM Degradation in Integrin β1 KO Embryonic Skin. | 3.43e-04 | 38 | 25 | 2 | 27653694 | |
| Pubmed | 3.43e-04 | 38 | 25 | 2 | 23273568 | ||
| Pubmed | 5.04e-04 | 46 | 25 | 2 | 25209997 | ||
| Pubmed | Genetic nomenclature for loci controlling surface antigens of mouse hemopoietic cells. | 6.68e-04 | 53 | 25 | 2 | 1431091 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 6.20e-05 | 797 | 25 | 5 | chr19p13 | |
| Cytoband | 19p13.1 | 3.16e-04 | 48 | 25 | 2 | 19p13.1 | |
| Cytoband | 19p13.2 | 6.89e-03 | 229 | 25 | 2 | 19p13.2 | |
| GeneFamily | Cytochrome P450 family 4 | 9.44e-08 | 36 | 22 | 4 | 1003 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.14e-04 | 18 | 22 | 2 | 1160 | |
| GeneFamily | Fibrinogen C domain containing | 4.17e-04 | 25 | 22 | 2 | 554 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.16e-02 | 394 | 22 | 3 | 471 | |
| GeneFamily | Fibronectin type III domain containing | 1.60e-02 | 160 | 22 | 2 | 555 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 8.64e-07 | 20 | 25 | 3 | MM1104 | |
| Coexpression | GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 3.32e-05 | 195 | 25 | 4 | M8134 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-06 | 181 | 25 | 4 | 4d7d367f4ed390908888391335c714a22b5a75c4 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-06 | 181 | 25 | 4 | cd81bc307e2bc42c1e9b24d5645ab65fa18c6133 | |
| ToppCell | P07-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.64e-06 | 190 | 25 | 4 | 5d25e40bc2cca314f4265e4001a546e6d99e2a79 | |
| ToppCell | Endothelial-Endothelial-B|Endothelial / shred on cell class and cell subclass (v4) | 3.79e-06 | 192 | 25 | 4 | f8d7bd81e031d09a557722627c2f6180811cc6ab | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.11e-06 | 196 | 25 | 4 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.11e-06 | 196 | 25 | 4 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.11e-06 | 196 | 25 | 4 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-06 | 196 | 25 | 4 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.11e-06 | 196 | 25 | 4 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.20e-06 | 197 | 25 | 4 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.46e-06 | 200 | 25 | 4 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-05 | 130 | 25 | 3 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | TCGA-Bladder|World / Sample_Type by Project: Shred V9 | 6.73e-05 | 142 | 25 | 3 | 58d1fdc5ec4e5bf307b7a502c081a8a84d7560cd | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9 | 7.92e-05 | 150 | 25 | 3 | 1aa9320d97ff10994ea024751790524fe133aba9 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.56e-05 | 154 | 25 | 3 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.72e-05 | 155 | 25 | 3 | 335cd798afbaa0a3a3e1dc558a81cfa32da48983 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 169 | 25 | 3 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 174 | 25 | 3 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 174 | 25 | 3 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 179 | 25 | 3 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.34e-04 | 179 | 25 | 3 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 179 | 25 | 3 | dfd9d29281510d32f1a2e8336d2e58ef496cfd1d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-04 | 179 | 25 | 3 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 179 | 25 | 3 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.36e-04 | 180 | 25 | 3 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 181 | 25 | 3 | 3dcb74b28f93be35ddf4de1937f7e30b25e11927 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 181 | 25 | 3 | 7679a5980011d6dfb1aaca7abf678c29b6f819bb | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 183 | 25 | 3 | 9e6c96ada930e8559246a270dfc69fb3cbb3bdf3 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-04 | 185 | 25 | 3 | 7b1c5d99bd7a6e148524029758cee244a17f5d09 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-04 | 185 | 25 | 3 | e9033a03d574956cf3ae228740b3166e40a6397f | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-04 | 185 | 25 | 3 | 578f12c6b2e33d09598dc8e022a20c8555d1325c | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-04 | 186 | 25 | 3 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 186 | 25 | 3 | 9d6cb36aa0aae69fe584dad31deafcfdcc9fd1db | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.50e-04 | 186 | 25 | 3 | 375642f353842184792a834361284d6897c728de | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.52e-04 | 187 | 25 | 3 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.52e-04 | 187 | 25 | 3 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-Late_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 188 | 25 | 3 | 38a53f99f1876359983936403aefca93281d10fd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-04 | 188 | 25 | 3 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 188 | 25 | 3 | 53213d0c907ce4522fc00699cb38fa78ed0bef7e | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.54e-04 | 188 | 25 | 3 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 25 | 3 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | P07-Endothelial-unknown_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.57e-04 | 189 | 25 | 3 | f515a04ae1746257d4568cea13a3dd75b4b05275 | |
| ToppCell | P07-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.57e-04 | 189 | 25 | 3 | fcfb28bd96471affc13e55aa7228f594aaa967cd | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-04 | 190 | 25 | 3 | 52213cd2a6a20772d4f49ba9ac0407abafa528db | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 190 | 25 | 3 | c1bfc1960a3df49c0f459454a7363804c32418ee | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 191 | 25 | 3 | 718330bb97fe8a1ffd0c82e9af23311a32eacfe1 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 191 | 25 | 3 | 454034ad940377ee079afa8ce33f8e0bdeaf44f8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.62e-04 | 191 | 25 | 3 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.62e-04 | 191 | 25 | 3 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 191 | 25 | 3 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-04 | 191 | 25 | 3 | 40e617d3c93f03ae87baf6c0b2304b617f5fe782 | |
| ToppCell | Endothelial-B|World / shred on cell class and cell subclass (v4) | 1.62e-04 | 191 | 25 | 3 | 8b7857dee69d0ba3e59e230c9fd372e14695299e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 191 | 25 | 3 | a25a5f9a380031fdaf57677a079f97a90f0550c0 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.64e-04 | 192 | 25 | 3 | ac9e5288ecd4b1e142f2e15a1fcd11c8eb9e15cd | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-04 | 192 | 25 | 3 | 9a1aeac3ecf31f865a23d8ee15a82aef31779089 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-04 | 192 | 25 | 3 | 2360824910cd471c8286ca369ba144d90d984602 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 1.64e-04 | 192 | 25 | 3 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-04 | 192 | 25 | 3 | 53d438e35c14e7656585942b788459e6d843c555 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 193 | 25 | 3 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | facs-Trachea-24m-Epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-04 | 193 | 25 | 3 | ec49a83b24371579d4ad46aad91c25115aa226f9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 193 | 25 | 3 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 193 | 25 | 3 | ac1073bf4d3868841226b850b058f1e27326a14e | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-04 | 194 | 25 | 3 | 8deeb3e00237e3d9ad5a1457cd0061576421b9e9 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 194 | 25 | 3 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 194 | 25 | 3 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-04 | 194 | 25 | 3 | b81801fb16e8bd0d6083fe32866051d3c60f3dc7 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 194 | 25 | 3 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-04 | 195 | 25 | 3 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|normal_Lung / Location, Cell class and cell subclass | 1.72e-04 | 195 | 25 | 3 | 569d1ebc5a5aa110a2430b096755ae35354040c4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-04 | 195 | 25 | 3 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-04 | 195 | 25 | 3 | 2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 195 | 25 | 3 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.72e-04 | 195 | 25 | 3 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-04 | 195 | 25 | 3 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.72e-04 | 195 | 25 | 3 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 1.72e-04 | 195 | 25 | 3 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 196 | 25 | 3 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | AT1|World / shred by cell class for parenchyma | 1.74e-04 | 196 | 25 | 3 | 2bc487f8a109a6961ebff111dec79c2227ea60ac | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 196 | 25 | 3 | ee89f6884aea11aefeaabe043db7f80145dcdf7f | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.74e-04 | 196 | 25 | 3 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-04 | 196 | 25 | 3 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-04 | 196 | 25 | 3 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-04 | 196 | 25 | 3 | faa39c567f24403e511b240c1d1a654ffadd8473 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 196 | 25 | 3 | 147dc1ca5942df48a083cce39a9a7541430f8365 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 196 | 25 | 3 | e75c36cb042342d69a593fb1ce62fab033889871 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 197 | 25 | 3 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 197 | 25 | 3 | c9c968e223e7814cd8d22975d849a31b7e0af7aa | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 197 | 25 | 3 | e344455e62b3fe94bb242dc0db58d19a1d3878c7 | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.77e-04 | 197 | 25 | 3 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.77e-04 | 197 | 25 | 3 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 197 | 25 | 3 | 734b8db5bb4917c9ce92ed342fe6c22b64b0d3c5 | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 1.80e-04 | 198 | 25 | 3 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-04 | 198 | 25 | 3 | 9718f4c013c347f1b3c785ae232dd2fb6c1fe298 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-04 | 198 | 25 | 3 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.80e-04 | 198 | 25 | 3 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.80e-04 | 198 | 25 | 3 | 1fe51f4beca0eef4ff117e6edaa646e35c0f9629 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-04 | 198 | 25 | 3 | 54228dd9a50616d2022712d162a419ed0327cabd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-04 | 198 | 25 | 3 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-04 | 198 | 25 | 3 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-04 | 198 | 25 | 3 | 5375a2895cf995f0db4a61861093f01794707901 | |
| Computational | Genes in the cancer module 412. | 4.99e-07 | 13 | 14 | 3 | MODULE_412 | |
| Computational | Genes in the cancer module 275. | 9.75e-07 | 16 | 14 | 3 | MODULE_275 | |
| Computational | Adhesion molecules. | 2.56e-05 | 141 | 14 | 4 | MODULE_122 | |
| Computational | Lung genes. | 1.55e-04 | 434 | 14 | 5 | MODULE_5 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Computational | Genes in the cancer module 18. | 2.19e-03 | 451 | 14 | 4 | MODULE_18 | |
| Drug | propoxyphene | 8.27e-07 | 67 | 25 | 4 | CID000010100 | |
| Drug | carteolol | 1.11e-06 | 72 | 25 | 4 | CID000002583 | |
| Drug | trimipramine | 1.69e-06 | 80 | 25 | 4 | CID000005584 | |
| Drug | alprazolam | 1.92e-06 | 193 | 25 | 5 | CID000002118 | |
| Drug | diosmetin | 2.16e-06 | 85 | 25 | 4 | CID005281612 | |
| Drug | mephenytoin | 2.48e-06 | 88 | 25 | 4 | CID000004060 | |
| Drug | tienilic acid | 3.09e-06 | 93 | 25 | 4 | CID000038409 | |
| Drug | lansoprazole | 3.09e-06 | 93 | 25 | 4 | CID000003883 | |
| Drug | C14845 | 3.36e-06 | 27 | 25 | 3 | CID011954064 | |
| Drug | BP-9,10-oxide | 3.36e-06 | 27 | 25 | 3 | CID000037456 | |
| Drug | Brn 4136738 | 3.36e-06 | 27 | 25 | 3 | CID000050331 | |
| Drug | 9-OH-BaP-4,5-oxide | 3.76e-06 | 28 | 25 | 3 | CID000115064 | |
| Drug | AC1L1KIN | 4.13e-06 | 100 | 25 | 4 | CID000005516 | |
| Drug | Sparteinum | 4.30e-06 | 101 | 25 | 4 | CID000003966 | |
| Drug | 11-H-14,15-EETA | 4.66e-06 | 30 | 25 | 3 | CID011954058 | |
| Drug | 19-hydroxytestosterone | 4.66e-06 | 30 | 25 | 3 | CID000150968 | |
| Drug | BP-7,8-oxide | 5.68e-06 | 32 | 25 | 3 | CID000037455 | |
| Drug | TCEO | 6.84e-06 | 34 | 25 | 3 | CID000028167 | |
| Drug | 12(13)-EpOME | 6.84e-06 | 34 | 25 | 3 | CID000001416 | |
| Drug | AC1O5XSP | 6.84e-06 | 34 | 25 | 3 | CID006442739 | |
| Drug | 3-ethylpyridine | 6.94e-06 | 4 | 25 | 2 | CID000010823 | |
| Drug | AC1L1CJI | 7.48e-06 | 35 | 25 | 3 | CID000001929 | |
| Drug | AC1Q7AUJ | 7.71e-06 | 117 | 25 | 4 | CID000003303 | |
| Drug | 8-MOP | 7.97e-06 | 118 | 25 | 4 | CID000004114 | |
| Drug | 15-H-11,12-EETA | 8.15e-06 | 36 | 25 | 3 | CID011954042 | |
| Drug | AC1L3NGJ | 8.15e-06 | 36 | 25 | 3 | CID000092121 | |
| Drug | NSC98537 | 9.86e-06 | 473 | 25 | 6 | CID000005410 | |
| Drug | 11,14,15-THET | 1.04e-05 | 39 | 25 | 3 | CID006439531 | |
| Drug | hexobarbital | 1.07e-05 | 127 | 25 | 4 | CID000003608 | |
| Drug | chloral hydrate | 1.13e-05 | 129 | 25 | 4 | CID000002707 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 1.31e-05 | 42 | 25 | 3 | CID006439610 | |
| Drug | aminoglutethimide | 1.44e-05 | 137 | 25 | 4 | CID000002145 | |
| Drug | polybrominated biphenyl | 1.50e-05 | 44 | 25 | 3 | CID000042948 | |
| Drug | naphthalene-1,2-dihydrodiol | 1.61e-05 | 45 | 25 | 3 | CID000000362 | |
| Drug | AC1O5SNJ | 1.73e-05 | 6 | 25 | 2 | CID006439900 | |
| Drug | C14802 | 1.84e-05 | 47 | 25 | 3 | CID011954053 | |
| Drug | C14800 | 1.96e-05 | 48 | 25 | 3 | CID011954051 | |
| Drug | nitro-L | 1.96e-05 | 48 | 25 | 3 | CID000006849 | |
| Drug | 19-HETE | 2.08e-05 | 49 | 25 | 3 | CID006439528 | |
| Drug | bromobenzene-3,4-oxide | 2.08e-05 | 49 | 25 | 3 | CID000108121 | |
| Drug | 6-hydroxymelatonin | 2.22e-05 | 50 | 25 | 3 | CID000001864 | |
| Drug | 1,1-dichloroethylene epoxide | 2.22e-05 | 50 | 25 | 3 | CID000119521 | |
| Drug | bromobenzene-2,3-oxide | 2.22e-05 | 50 | 25 | 3 | CID003036760 | |
| Drug | naphthalene epoxide | 2.35e-05 | 51 | 25 | 3 | CID000108063 | |
| Drug | 9-hydroxybenzo(a)pyrene | 2.64e-05 | 53 | 25 | 3 | CID000028598 | |
| Drug | dichloroacetaldehyde | 2.80e-05 | 54 | 25 | 3 | CID000006576 | |
| Drug | paraoxon | 2.92e-05 | 164 | 25 | 4 | CID000009395 | |
| Drug | chloroacetyl chloride | 2.95e-05 | 55 | 25 | 3 | CID000006577 | |
| Drug | deferoxamine | 3.12e-05 | 343 | 25 | 5 | CID000002973 | |
| Drug | AC1L1KKK | 3.23e-05 | 8 | 25 | 2 | CID000005539 | |
| Drug | felodipine | 3.28e-05 | 169 | 25 | 4 | CID000003333 | |
| Drug | 1,2-dihydroxynaphthalene | 3.29e-05 | 57 | 25 | 3 | CID000011318 | |
| Drug | dioxin | 3.30e-05 | 347 | 25 | 5 | CID000015625 | |
| Drug | aminopyrine | 3.44e-05 | 171 | 25 | 4 | CID000006009 | |
| Drug | bromoacetaldehyde | 3.47e-05 | 58 | 25 | 3 | CID000105131 | |
| Drug | 1,1-dichloroethylene | 3.84e-05 | 60 | 25 | 3 | CID000006366 | |
| Drug | BP-4,5-oxide | 4.04e-05 | 61 | 25 | 3 | CID000037786 | |
| Drug | metyrapone | 4.11e-05 | 179 | 25 | 4 | CID000004174 | |
| Drug | AC1L1F4K | 4.15e-05 | 9 | 25 | 2 | CID000003079 | |
| Drug | (Z)-7-[(1S,4R,6R)-5-[(E)-oct-1-enyl]-2,3-diazabicyclo[2.2.1]hept-2-en-6-yl]hept-5-enoic acid | 5.18e-05 | 10 | 25 | 2 | CID009905657 | |
| Drug | 18-HETE | 5.18e-05 | 10 | 25 | 2 | CID006442778 | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 5.18e-05 | 190 | 25 | 4 | 5579_UP | |
| Drug | piperonyl butoxide | 5.35e-05 | 67 | 25 | 3 | CID000005794 | |
| Drug | 5,6-epoxyeicosatrienoic acid | 5.59e-05 | 68 | 25 | 3 | CID000001778 | |
| Drug | 8(9)-EET | 5.84e-05 | 69 | 25 | 3 | CID000001901 | |
| Drug | tolbutamide | 6.08e-05 | 198 | 25 | 4 | CID000005505 | |
| Drug | 4-bromophenol | 6.10e-05 | 70 | 25 | 3 | CID000007808 | |
| Drug | 1,2-dibromoethane | 6.36e-05 | 71 | 25 | 3 | CID000007839 | |
| Drug | 2,2,2-trichloroethanol | 6.91e-05 | 73 | 25 | 3 | CID000008259 | |
| Drug | chloral | 6.91e-05 | 73 | 25 | 3 | CID000006407 | |
| Drug | diclofenac | 7.50e-05 | 209 | 25 | 4 | CID000003032 | |
| Drug | BP-7,8-diol | 8.43e-05 | 78 | 25 | 3 | CID000025892 | |
| Drug | C20H32O4 | 8.43e-05 | 78 | 25 | 3 | CID000001440 | |
| Drug | azo analog I | 8.96e-05 | 13 | 25 | 2 | CID006438575 | |
| Drug | paricalcitol | 1.17e-04 | 87 | 25 | 3 | ctd:C084656 | |
| Drug | trichloroethylene | 1.21e-04 | 88 | 25 | 3 | CID000006575 | |
| Drug | 3 -hydroxypregn-5-en-20-one | 1.24e-04 | 238 | 25 | 4 | CID000001027 | |
| Drug | 14(15)-EpETrE | 1.25e-04 | 89 | 25 | 3 | CID000001431 | |
| Drug | Rgd Peptide | 1.26e-04 | 239 | 25 | 4 | CID000104802 | |
| Drug | parathion | 1.33e-04 | 91 | 25 | 3 | CID000000991 | |
| Drug | 2-naphthol | 1.42e-04 | 93 | 25 | 3 | CID000008663 | |
| Drug | AC1L1BEQ | 1.42e-04 | 93 | 25 | 3 | CID000001407 | |
| Drug | bromobenzene | 1.61e-04 | 97 | 25 | 3 | CID000007961 | |
| Drug | propafenone | 1.66e-04 | 98 | 25 | 3 | CID000004932 | |
| Drug | PCB 77 | 1.66e-04 | 98 | 25 | 3 | CID000036187 | |
| Drug | oxygen | 1.83e-04 | 499 | 25 | 5 | CID000000977 | |
| Drug | trichloroacetic acid | 2.15e-04 | 107 | 25 | 3 | CID000006421 | |
| Drug | NSC3077 | 2.17e-04 | 20 | 25 | 2 | CID000025889 | |
| Drug | proadifen hydrochloride | 2.59e-04 | 114 | 25 | 3 | CID000004910 | |
| Drug | alpha-naphthoflavone | 2.87e-04 | 118 | 25 | 3 | CID000011790 | |
| Drug | benzphetamine | 2.94e-04 | 119 | 25 | 3 | CID000002341 | |
| Drug | rifampicin | 3.24e-04 | 306 | 25 | 4 | CID005381226 | |
| Drug | naphthalene | 3.24e-04 | 123 | 25 | 3 | CID000000931 | |
| Drug | ebastine | 3.42e-04 | 25 | 25 | 2 | CID000003191 | |
| Drug | clofibrate | 3.44e-04 | 311 | 25 | 4 | CID000002796 | |
| Drug | halothane | 3.57e-04 | 314 | 25 | 4 | CID000003562 | |
| Drug | sodium linoleate | 4.93e-04 | 342 | 25 | 4 | CID000003931 | |
| Drug | aniline | 4.94e-04 | 142 | 25 | 3 | CID000006115 | |
| Drug | 2 E1 | 5.25e-04 | 145 | 25 | 3 | CID006102788 | |
| Drug | cyclofenil | 5.28e-04 | 31 | 25 | 2 | CID000002898 | |
| Disease | tenascin measurement | 3.09e-05 | 10 | 25 | 2 | EFO_0008296 | |
| Disease | undecenoylcarnitine (C11:1) measurement | 5.34e-05 | 13 | 25 | 2 | EFO_0800588 | |
| Disease | systemic lupus erythematosus | 4.87e-04 | 799 | 25 | 5 | MONDO_0007915 | |
| Disease | lung cancer (is_marker_for) | 5.01e-04 | 39 | 25 | 2 | DOID:1324 (is_marker_for) | |
| Disease | systemic lupus erythematosus, COVID-19 | 1.11e-03 | 58 | 25 | 2 | MONDO_0007915, MONDO_0100096 | |
| Disease | Libman-Sacks Disease | 1.11e-03 | 58 | 25 | 2 | C0242380 | |
| Disease | susceptibility to cold sores measurement | 1.39e-03 | 65 | 25 | 2 | EFO_0008402 | |
| Disease | Lupus Erythematosus, Systemic | 1.65e-03 | 71 | 25 | 2 | C0024141 | |
| Disease | ulcerative colitis | 2.77e-03 | 335 | 25 | 3 | EFO_0000729 | |
| Disease | neurotic disorder | 3.31e-03 | 101 | 25 | 2 | EFO_0004257 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSSGGMFITTGSTDH | 326 | Q6RI45 | |
| TFMSGTHSTASQGFS | 9101 | Q8WXI7 | |
| SAAMGADFHFSSTLG | 276 | Q9H9Y4 | |
| FAGSESAVFHGFFSM | 531 | P26006 | |
| FASTFFMQDGTHNSS | 221 | Q99081 | |
| SMFSDDFGSFMRPHS | 46 | Q9UBY9 | |
| EADTFMFGGHDTTAS | 321 | P98187 | |
| EADTFMFGGHDTTAS | 321 | Q9HCS2 | |
| TFMFEGHDTTTSGIS | 311 | P13584 | |
| ADHSTAMGFCFFNSV | 671 | Q8WUI4 | |
| QGSGFFMHFDSSSVN | 306 | Q16820 | |
| TFMFEGHDTTSSGIS | 331 | Q6NT55 | |
| SSTVSGFFAAASFMS | 456 | Q96DX4 | |
| RLFSHEGSSFQMFSS | 301 | P08582 | |
| MSSSFFNPSFAFSSH | 1 | Q6ZMQ8 | |
| APHSAFSFTGAAASM | 491 | O75626 | |
| GSSSSFEHEMSQEGF | 341 | P11215 | |
| MADDFGFFSSSESGA | 1 | P09497 | |
| RFAAFGESSSSGTEM | 11 | P59282 | |
| SRFSEFTGFSGMSFS | 551 | Q9UPV9 | |
| DFSGSSFEMTTGHTY | 161 | Q9UKR8 | |
| ASAFGSSTDSMFSRF | 31 | Q8N1Q8 | |
| AGDSMSYHSGSVFSA | 4156 | P22105 | |
| GDSMAYHNGRSFSTF | 2111 | P24821 | |
| SGMDTEFGASSFFHS | 911 | Q70EL1 |